The worldwide healthcare landscape is experiencing a huge increase in demand for cardiology products as the prevalence of cardiovascular diseases (CVDs) rises. Hence, contract manufacturing for cardiology products is emerging as a vast opportunity for the pharmaceutical companies, in terms of scalability, quality, and cost.
The market forecast of this industry is affected by the rise of cardiology products all over India. Cardiovascular diseases cause ~30% of the world mortality, which causes cardiology to be one of the most significant and demanded therapy areas in the pharmaceutical sector.
Furthermore, the global cardiovascular drugs market is expected to cross USD 70 billion in the year 2030 alone globally and India is poised to become a major manufacturing epicenter on account of low costs of production and compliance. Yet there is a mass market for antihypertensives beta-blockers, calcium channel blockers, statins, and anticoagulants. Also, combination medications for cardiovascular and diabetes disorders are in huge demand across India.
As a result, the future of cardiology medicine contract manufacturing services is bright and promising. With the rising frequency of CVDs and increased demand for high-quality cardiac medications, pharmaceutical businesses, particularly those without in-house manufacturing, can achieve rapid growth by collaborating with reputable third party cardiac diabetic products manufacturer.
Factors influencing Contract Manufacturing for Cardiology Products
The following factors will contribute to the growth of the cardiology medicine contract manufacturing services industry in India and worldwide:
There’s massive penetration in India. Cardiovascular disease is the biggest killer globally, and in India, it is responsible for over 28% of heart disease deaths. In addition, increased incidence of hypertension, obesity, diabetes, and lack of physical activity is prompting healthcare providers and researchers to scale up production.
Increase in generic and affordable cardiac medicines:
When the patents on branded cardiovascular medications expire, the market opens up for low-cost generic alternatives. With this, Indian contract manufacturers produce these generics at a low cost while maintaining good quality.
Government health programs and insurance coverage:
The new age India has various important schemes like Ayushman Bharat. And greater public health funding is making cardiac medications more affordable. Hence, this increased consumer affordability drives up demand for cardiac medications.
Technological advancements in formulations:
The use of sustained-release, combination treatments and bilayer tablets in cardiac care is in demand. In that situation, contract manufacturing for heart medicines companies provides the benefits of superior research and development capabilities.
Global market outsourcing trends:
Many worldwide corporations outsource API and FDF (finished dosage form) manufacture to India because of:
Low labour costs
WHO-GMP/FDA compliance
Skilled workforce
Demand for pharma marketing and pcd companies:
A growing number of cardiac diabetic pcd franchise and startups in cardiac-diabetic market require reputable manufacturers to support private-label brands.
Regulatory emphasis on quality & certification:
Today, clients increasingly choose WHO-GMP, ISO, and US FDA-compliant units. This helps them to expand their business and sell products to individuals throughout the world.
Lifestyle awareness and preventive cardiac care:
Middle-aged and older people are increasingly turning to preventive cardiac supplements, statins, and antiplatelet medicines. Thus, it increases the demand for cardiac medicines.
Top Critical Steps for Manufacturing Cardiology Medicines at Cardiovends
In our company, cardiology drugs are manufactured using a variety of well-regulated methods to ensure their safety, efficacy, and quality. The following are the essential stages we always take to make cardiovascular medications in tablet, capsule, or injectable form:
Pre-formulation research objective: To comprehend the medicine’s physical and chemical characteristics, we include:
Drug solubility studies
Stability testing
Compatible with excipients
This means stability and binding tests are required for medications such as atenolol and clopidogrel.
Formulation development: We offer a different choice of dose form (tablet, pill, injectable). Thus, we always choose suitable excipients (binders, fillers, and disintegrants); also, we design formulas with immediate or sustained release.
Procurement of raw materials (api + excipients): We choose only active pharmaceutical ingredients (APIs), including atorvastatin, amlodipine, losartan, etc. All of our raw materials must meet pharmaceutical standards (IP, usp, BP).
Granulation (for tablets): In this, the api and excipients are mixed uniformly. And we also ensure granulation, either wet or dry, is used to improve compressibility. Then our granules are dried and prepared for compression. Hence, this step ensures consistent dosage and pill strength.
Compression or encapsulation tablets: At this time, granules are compressed by tablet machines. Also in capsules, the powdered blend is placed within capsules (hard or soft gelatin). Most importantly, uniform weight, hardness, and disintegration time are evaluated.
Quality control testing tablets: One of the most important elements of our manufacturing process is that we always ensure that all of our products go through
Dissolution
Disintegration
Uniformity of weight
Assay (potency).
Microbial testing (injectables)
We also fulfill regulatory standards (WHO-GMP, FDA, etc.).
Finalization
To come to the finalisation of this whole discussion, we tell you that there is a huge business scope and demand for the contract manufacturing for heart medicines all over India. Also, Cardiovends is the leading brand name in this sector that offers genuine cardiology medicine contract manufacturing services. Hence, to get cost-efficient and reliable manufacturing services, we have always proven to be the best platform.
